Selected research
Industry Research
Avermectin Pour-on Solution Industry Research Report 2026
Market perspective
The global Avermectin Pour-on Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Avermectin Pour-on Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Avermectin Pour-on Solution is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Avermectin Pour-on Solution is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Avermectin Pour-on Solution include Sichuan Weierkang Animal Pharmacy Group, Shandong Yahua Biological Technology, Shandong Hope Biotech, Harbin Qianhe Animal Drug Manufacturing, Luoyang Langwei Animal Pharmaceutical, Creator, Henan Liangdian Group, Chongqing Fangtong Animal Pharmaceutical and Veyong Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Avermectin Pour-on Solution market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Avermectin Pour-on Solution Market by Company
Sichuan Weierkang Animal Pharmacy Group
Shandong Yahua Biological Technology
Shandong Hope Biotech
Harbin Qianhe Animal Drug Manufacturing
Luoyang Langwei Animal Pharmaceutical
Creator
Henan Liangdian Group
Chongqing Fangtong Animal Pharmaceutical
Veyong Pharma
Norbrook
Laboratorios Microsules Uruguay
Interchemie
Chanelle Pharma
Boehringer Ingelheim Animal Health
AdvaCare Pharma
Avermectin Pour-on Solution Segment by Type
Special Type
General Type
Avermectin Pour-on Solution Segment by Application
Dog
Cow
Cat
Others
Avermectin Pour-on Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avermectin Pour-on Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Avermectin Pour-on Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avermectin Pour-on Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Avermectin Pour-on Solution manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Avermectin Pour-on Solution by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Avermectin Pour-on Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Special Type
- General Type
Applications
- Dog
- Cow
- Cat
- Others
Companies covered
- Sichuan Weierkang Animal Pharmacy Group
- Shandong Yahua Biological Technology
- Shandong Hope Biotech
- Harbin Qianhe Animal Drug Manufacturing
- Luoyang Langwei Animal Pharmaceutical
- Creator
- Henan Liangdian Group
- Chongqing Fangtong Animal Pharmaceutical
- Veyong Pharma
- Norbrook
- Laboratorios Microsules Uruguay
- Interchemie
- Chanelle Pharma
- Boehringer Ingelheim Animal Health
- AdvaCare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Avermectin Pour-on Solution Market Size (2021-2032)
- 2.2.2 Global Avermectin Pour-on Solution Sales (2021-2032)
- 2.2.3 Global Avermectin Pour-on Solution Market Average Price (2021-2032)
- 2.3 Avermectin Pour-on Solution by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Special Type
- 2.3.3 General Type
- 2.4 Avermectin Pour-on Solution by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dog
- 2.4.3 Cow
- 2.4.4 Cat
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Avermectin Pour-on Solution Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Avermectin Pour-on Solution Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Avermectin Pour-on Solution Revenue of Manufacturers (2021-2026)
- 3.4 Global Avermectin Pour-on Solution Average Price by Manufacturers (2021-2026)
- 3.5 Global Avermectin Pour-on Solution Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Avermectin Pour-on Solution, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Avermectin Pour-on Solution, Product Type & Application
- 3.8 Global Manufacturers of Avermectin Pour-on Solution, Established Date
- 3.9 Global Avermectin Pour-on Solution Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sichuan Weierkang Animal Pharmacy Group
- 4.1.1 Sichuan Weierkang Animal Pharmacy Group Company Information
- 4.1.2 Sichuan Weierkang Animal Pharmacy Group Business Overview
- 4.1.3 Sichuan Weierkang Animal Pharmacy Group Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sichuan Weierkang Animal Pharmacy Group Avermectin Pour-on Solution Product Portfolio
- 4.1.5 Sichuan Weierkang Animal Pharmacy Group Recent Developments
- 4.2 Shandong Yahua Biological Technology
- 4.2.1 Shandong Yahua Biological Technology Company Information
- 4.2.2 Shandong Yahua Biological Technology Business Overview
- 4.2.3 Shandong Yahua Biological Technology Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shandong Yahua Biological Technology Avermectin Pour-on Solution Product Portfolio
- 4.2.5 Shandong Yahua Biological Technology Recent Developments
- 4.3 Shandong Hope Biotech
- 4.3.1 Shandong Hope Biotech Company Information
- 4.3.2 Shandong Hope Biotech Business Overview
- 4.3.3 Shandong Hope Biotech Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Hope Biotech Avermectin Pour-on Solution Product Portfolio
- 4.3.5 Shandong Hope Biotech Recent Developments
- 4.4 Harbin Qianhe Animal Drug Manufacturing
- 4.4.1 Harbin Qianhe Animal Drug Manufacturing Company Information
- 4.4.2 Harbin Qianhe Animal Drug Manufacturing Business Overview
- 4.4.3 Harbin Qianhe Animal Drug Manufacturing Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Harbin Qianhe Animal Drug Manufacturing Avermectin Pour-on Solution Product Portfolio
- 4.4.5 Harbin Qianhe Animal Drug Manufacturing Recent Developments
- 4.5 Luoyang Langwei Animal Pharmaceutical
- 4.5.1 Luoyang Langwei Animal Pharmaceutical Company Information
- 4.5.2 Luoyang Langwei Animal Pharmaceutical Business Overview
- 4.5.3 Luoyang Langwei Animal Pharmaceutical Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Luoyang Langwei Animal Pharmaceutical Avermectin Pour-on Solution Product Portfolio
- 4.5.5 Luoyang Langwei Animal Pharmaceutical Recent Developments
- 4.6 Creator
- 4.6.1 Creator Company Information
- 4.6.2 Creator Business Overview
- 4.6.3 Creator Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Creator Avermectin Pour-on Solution Product Portfolio
- 4.6.5 Creator Recent Developments
- 4.7 Henan Liangdian Group
- 4.7.1 Henan Liangdian Group Company Information
- 4.7.2 Henan Liangdian Group Business Overview
- 4.7.3 Henan Liangdian Group Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Henan Liangdian Group Avermectin Pour-on Solution Product Portfolio
- 4.7.5 Henan Liangdian Group Recent Developments
- 4.8 Chongqing Fangtong Animal Pharmaceutical
- 4.8.1 Chongqing Fangtong Animal Pharmaceutical Company Information
- 4.8.2 Chongqing Fangtong Animal Pharmaceutical Business Overview
- 4.8.3 Chongqing Fangtong Animal Pharmaceutical Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chongqing Fangtong Animal Pharmaceutical Avermectin Pour-on Solution Product Portfolio
- 4.8.5 Chongqing Fangtong Animal Pharmaceutical Recent Developments
- 4.9 Veyong Pharma
- 4.9.1 Veyong Pharma Company Information
- 4.9.2 Veyong Pharma Business Overview
- 4.9.3 Veyong Pharma Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Veyong Pharma Avermectin Pour-on Solution Product Portfolio
- 4.9.5 Veyong Pharma Recent Developments
- 4.10 Norbrook
- 4.10.1 Norbrook Company Information
- 4.10.2 Norbrook Business Overview
- 4.10.3 Norbrook Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Norbrook Avermectin Pour-on Solution Product Portfolio
- 4.10.5 Norbrook Recent Developments
- 4.11 Laboratorios Microsules Uruguay
- 4.11.1 Laboratorios Microsules Uruguay Company Information
- 4.11.2 Laboratorios Microsules Uruguay Business Overview
- 4.11.3 Laboratorios Microsules Uruguay Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Laboratorios Microsules Uruguay Avermectin Pour-on Solution Product Portfolio
- 4.11.5 Laboratorios Microsules Uruguay Recent Developments
- 4.12 Interchemie
- 4.12.1 Interchemie Company Information
- 4.12.2 Interchemie Business Overview
- 4.12.3 Interchemie Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Interchemie Avermectin Pour-on Solution Product Portfolio
- 4.12.5 Interchemie Recent Developments
- 4.13 Chanelle Pharma
- 4.13.1 Chanelle Pharma Company Information
- 4.13.2 Chanelle Pharma Business Overview
- 4.13.3 Chanelle Pharma Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Chanelle Pharma Avermectin Pour-on Solution Product Portfolio
- 4.13.5 Chanelle Pharma Recent Developments
- 4.14 Boehringer Ingelheim Animal Health
- 4.14.1 Boehringer Ingelheim Animal Health Company Information
- 4.14.2 Boehringer Ingelheim Animal Health Business Overview
- 4.14.3 Boehringer Ingelheim Animal Health Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Boehringer Ingelheim Animal Health Avermectin Pour-on Solution Product Portfolio
- 4.14.5 Boehringer Ingelheim Animal Health Recent Developments
- 4.15 AdvaCare Pharma
- 4.15.1 AdvaCare Pharma Company Information
- 4.15.2 AdvaCare Pharma Business Overview
- 4.15.3 AdvaCare Pharma Avermectin Pour-on Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 AdvaCare Pharma Avermectin Pour-on Solution Product Portfolio
- 4.15.5 AdvaCare Pharma Recent Developments
5 Global Avermectin Pour-on Solution Market Scenario by Region
- 5.1 Global Avermectin Pour-on Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Avermectin Pour-on Solution Sales by Region: 2021-2032
- 5.2.1 Global Avermectin Pour-on Solution Sales by Region: 2021-2026
- 5.2.2 Global Avermectin Pour-on Solution Sales by Region: 2027-2032
- 5.3 Global Avermectin Pour-on Solution Revenue by Region: 2021-2032
- 5.3.1 Global Avermectin Pour-on Solution Revenue by Region: 2021-2026
- 5.3.2 Global Avermectin Pour-on Solution Revenue by Region: 2027-2032
- 5.4 North America Avermectin Pour-on Solution Market Facts & Figures by Country
- 5.4.1 North America Avermectin Pour-on Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Avermectin Pour-on Solution Sales by Country (2021-2032)
- 5.4.3 North America Avermectin Pour-on Solution Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Avermectin Pour-on Solution Market Facts & Figures by Country
- 5.5.1 Europe Avermectin Pour-on Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Avermectin Pour-on Solution Sales by Country (2021-2032)
- 5.5.3 Europe Avermectin Pour-on Solution Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Avermectin Pour-on Solution Market Facts & Figures by Country
- 5.6.1 Asia Pacific Avermectin Pour-on Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Avermectin Pour-on Solution Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Avermectin Pour-on Solution Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Avermectin Pour-on Solution Market Facts & Figures by Country
- 5.7.1 South America Avermectin Pour-on Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Avermectin Pour-on Solution Sales by Country (2021-2032)
- 5.7.3 South America Avermectin Pour-on Solution Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Avermectin Pour-on Solution Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Avermectin Pour-on Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Avermectin Pour-on Solution Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Avermectin Pour-on Solution Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Avermectin Pour-on Solution Sales by Type (2021-2032)
- 6.1.1 Global Avermectin Pour-on Solution Sales by Type (2021-2032) & (t)
- 6.1.2 Global Avermectin Pour-on Solution Sales Market Share by Type (2021-2032)
- 6.2 Global Avermectin Pour-on Solution Revenue by Type (2021-2032)
- 6.2.1 Global Avermectin Pour-on Solution Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Avermectin Pour-on Solution Revenue Market Share by Type (2021-2032)
- 6.3 Global Avermectin Pour-on Solution Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Avermectin Pour-on Solution Sales by Application (2021-2032)
- 7.1.1 Global Avermectin Pour-on Solution Sales by Application (2021-2032) & (t)
- 7.1.2 Global Avermectin Pour-on Solution Sales Market Share by Application (2021-2032)
- 7.2 Global Avermectin Pour-on Solution Revenue by Application (2021-2032)
- 7.2.1 Global Avermectin Pour-on Solution Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Avermectin Pour-on Solution Revenue Market Share by Application (2021-2032)
- 7.3 Global Avermectin Pour-on Solution Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Avermectin Pour-on Solution Value Chain Analysis
- 8.1.1 Avermectin Pour-on Solution Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Avermectin Pour-on Solution Production Mode & Process
- 8.2 Avermectin Pour-on Solution Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Avermectin Pour-on Solution Distributors
- 8.2.3 Avermectin Pour-on Solution Customers
9 Global Avermectin Pour-on Solution Analyzing Market Dynamics
- 9.1 Avermectin Pour-on Solution Industry Trends
- 9.2 Avermectin Pour-on Solution Industry Drivers
- 9.3 Avermectin Pour-on Solution Industry Opportunities and Challenges
- 9.4 Avermectin Pour-on Solution Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst